When combined with CpG ODN and ISCOM, recombinant human HCA587 protein induced strong antigen-specific immune responses, which was capable of protecting immunized mice against the challenge of HCA587-expressing B16 melanoma, inhibiting the growth of established tumor and enhancing the survival of tumor-bearing mice. The gene discussed is MAGEC2; the disease is melanoma.